Comparison of 2.0 mg/kg Sugammadex and Neostigmine at Reappearance of T2 in Chinese and European Subjects (Study 19.4.324)(P05768AM1)(COMPLETED)

NCT00825812 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

308

Enrollment

INDUSTRY

Sponsor class

Conditions

Anesthesia, General
Neuromuscular Blockade

Interventions

DRUG: Sugammadex
DRUG: neostigmine

Sponsor

Merck Sharp & Dohme LLC